Antag Therapeutics
DenmarkEntry
2017
Hold
9yr
Status
Active
Who owns Antag Therapeutics?
Antag Therapeutics is a Danish Biotech company, currently owned by Eifo since 2024 and Novo Holdings.
Hand-verified · updated 2026-08-18
Open JSON · CC-BY
Most recent investor
Novo HoldingsNovo Holdings Seed Investments · 1999 · VC
2 ownership periods · full history below
Key facts
HQDenmark
SectorBiotech
StatusActive
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2017 · present
Novo HoldingsActive
2017 · present(9yr) · Novo Holdings Seed Investments · 1999 · VC
EifoActive
2024 · present(2yr) · EIFO (direct equity) · 1992 · VC
More from Novo Holdings Seed Investments
Other portfolio companies in the same fund.
US
GermanyMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Antag Therapeutics?
Antag Therapeutics is currently owned by Eifo and Novo Holdings, through Novo Holdings Seed Investments, since 2024.
When did Eifo and 1 other acquire Antag Therapeutics?
Eifo and 1 other acquired Antag Therapeutics in 2024.
Who has owned Antag Therapeutics over time?
Antag Therapeutics has been through 2 private-equity ownership periods: Novo Holdings · via Novo Holdings Seed Investments · since 2017; Eifo · via EIFO (direct equity) · since 2024.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue